A novel “chemical assembly line” that uses a ribbon made of polymer mesh that has sachet pockets containing a solid-phase resin that moves continuously through all the various chemical stages of manufacture.
The solvents, which react with the resin to produce the peptide, move in a counter current allowing for full utilization of the chemicals to minimize use of these toxic chemicals.
μLOT® modules are easily transportable anywhere and at any time due to their modular nature.
SB3000 partners with Evaxion Biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology.
Lars Wegner CEO of Evaxion commented
“We believe that it requires high levels of innovation to design and develop a new vaccine very rapidly... We expect that the SB3000 μLOT® technology for continuous manufacturing of peptides will allow us to accelerate design, development and supply. The manufacturing process will be developed at scale during pre-clinical studies and, upon validation, we expect that this method will be scaled out and moved straight into commercial production with no further development required, at a fraction of the traditional manufacturing cost.”
Reduction in the use of toxic chemicals by up to 100 times.
Dramatically reducing existing capital costs and making it possible to avoid building new multi-billion dollar manufacturing plants.
μLOT® modules are easily transportable anywhere and at any time due to their modular nature and smaller footprint, enabling multiple on-shore manufacturing operations that can be commissioned more rapidly.
The μLOT® technology enables adjustments to be made to the existing continuous manufacturing production line to accommodate different types of pharmaceuticals. No need to build a new plant.
Composite ribbon technology based on Krebs cycle - a series of chemical reactions used by all aerobic organisms to generate energy